A precise dose verification device for tumor patients
A technology for tumor patients and dose verification, applied in the field of accurate dose verification for tumor patients, can solve the problems of relying on doctors' subjective judgment, accurate execution, and lack of unified standards, so as to improve efficiency and result consistency, accurate QA prediction, and high evaluation efficiency Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0044] It should be noted that, in the case of no conflict, the embodiments in the present application and the features in the embodiments can be combined with each other. The present invention will be described in detail below with reference to the accompanying drawings and examples.
[0045] It should be noted that, unless otherwise specified, all technical and scientific terms used in this application have the same meaning as commonly understood by those of ordinary skill in the art to which this application belongs.
[0046] refer to figure 1 , the invention discloses a precise dose verification method for tumor patients, comprising:
[0047] 101. Establish an information database of tumor patients.
[0048] Based on existing clinical data, such as nasopharyngeal carcinoma and prostate cancer and other clinical common tumor patients, the IMRT / VMAT plan QA subjectively and objectively analyzes the information data of tumor patients. The information data is usually raw dat...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com